| Financial Year |
March 31 2023 |
| Monetary Funds |
1,784,480,299.30 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
43,807,935.71 |
| Advances to Suppliers |
15,990,563.33 |
| Other Receivables |
1,654,828.86 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
80,326,926.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,638,905.95 |
| Total Current Assets |
2,080,218,387.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
330,222.32 |
| Long-term Equity Investment |
680,994,477.65 |
| Investment Properties |
-- |
| Fixed Assetes |
267,601,510.98 |
| Under-construction Projects |
12,910,492.47 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
244,226,366.43 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
29,461,101.41 |
| Other Non-Current Assets |
160,934.24 |
| Sub-Total of Non-Current Assets |
1,478,087,515.65 |
| Total Assets |
3,558,305,903.04 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
66,076,993.44 |
| Accounts Received In Advance |
1,225,000.00 |
| Employee Compensation Payable |
93,637,545.39 |
| Taxes Payable |
10,605,190.27 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
25,580,089.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
3,200,365.17 |
| Sub-Total of Current Liabilities |
224,943,376.97 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
28,313,191.16 |
| Deferred Income Tax Liabilities |
6,775,602.54 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
214,558,175.47 |
| Total Liabilities |
439,501,552.44 |
| Paid-In Capital(Or Share Stock) |
595,340,230.00 |
| Capital Surplus |
487,998,131.16 |
| Surplus Reserve |
321,768,154.77 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,649,213,750.44 |
| Minority Stockholder's Interest |
34,744,826.41 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,084,059,524.19 |
| Owner's Equity（Stockholder's Equity） |
3,118,804,350.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,558,305,903.04 |
